Unknown NA INTERVENTIONAL 1-arm NCT05374733

Coronary Physiology Peri-Transcatheter Left-sided Valvular Interventions (POTUS)

Coronary Physiology Peri-Transcatheter Left-sided Valvular Interventions in Patients With Severe Aortic Stenosis or Mitral Regurgitation

Sponsor: Erasmus Medical Center

Conditions Aortic Valve Stenosis Coronary Artery Disease Fractional Flow Reserve Mitral Regurgitation

Interventions Coronary Physiology assessment

Updated 4 times since 2022 Last updated: May 13, 2022 Started: Mar 22, 2021 Primary completion: Mar 1, 2023 Completion: Mar 1, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05374733, this NA trial focuses on Aortic Valve Stenosis and Coronary Artery Disease and remains ongoing. Sponsored by Erasmus Medical Center, it has been updated 4 times since 2021, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jun 2024 — Jul 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jun 2022 — Jun 2024 [monthly]

Recruiting NA

First recorded

Mar 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Erasmus Medical Center

Data source: Erasmus Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rotterdam, Netherlands